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Chlorhexidine Gluconate vs Povidone-Iodine in the Prevention of Clean-
Contaminated Surgical Site Infections 
Abby Stone, PA-S and Erin Layne, PA-S 
 
Abstract 
Background: 
A patient’s skin is the major source of pathogens that can cause post-operative complications 
such as surgical site infections (SSIs). Optimization of pre-operative skin antisepsis is obtained 
with chlorhexidine gluconate (CG) and povidone-iodine (PI). These two solutions are the most 
widely used antiseptics for pre-operative purposes.  
Objective:  
Among surgical patients greater than 18 years of age undergoing clean-contaminated surgery, 
which antiseptic, iodophors or chlorhexidine gluconate, is more effective at reducing 
postoperative surgical site infections? 
Methods: 
A search was done in PubMed utilizing the terms chlorhexidine, infection control, iodophors, 
and surgical site infection. The limits applied included randomized controlled trial, published 
within 10 years, and humans. 
Results:  
Darouiche et al found that the application of 2% CG reduced the incidence of SSIs by 41% 
compared to 10% PI. This study demonstrated statistical significance (p = 0.0049). Bibi et al 
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found a 45.4% reduction in SSI rates with the use of 2% CG compared to 10% PI but was not 
statistically significant (p =0.3961). Park et al found no difference between 2% CG and 10% PI 
regarding the reduction of SSIs (p= 0.8532).  
Conclusion:  
There is not a significant difference between the rates of SSIs when using CG compared to PI in 
the setting of clean-contaminated surgeries. Future research should be conducted to determine if 
a significant difference is present, and if there is a difference in efficacy of antiseptics in the 
settings of clean and contaminated wounds. CG and PI may be used interchangeably depending 
on presence of allergy, cost, and convenience. 
 
Introduction 
A surgical patient’s skin is the major source of pathogens that contribute to surgical site 
infections (SSIs). Most SSIs are caused by endogenous pathogens which are the patient’s native 
bacteria inhabiting the skin and body. Exogenous pathogens are those that come from an outside 
source such as unsterile surgical equipment or contaminants found in the air. SSIs are 
categorized as superficial incisional, deep incisional, or organ/space. 1 Incisional infections often 
manifest as cellulitis while deeper infections develop into abscesses. The degree of risk for 
infection post-operatively depends on the type of surgical wound involved. Clean-contaminated 
wounds have no evidence of infection at the time of surgery but involve operating on an internal 
organ. Other factors that increase risk for SSIs are diabetes, obesity, old age, weakened immune 
system, and cancer. 1 
Antimicrobial skin preparations are used before surgery as a means to reduce SSIs by reducing 
the endogenous pathogens on a patient’s skin. SSIs effect 300,000 to 500,000 surgical patients in 
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the United States each year and account for 29% of nosocomial infections.2 These infections 
necessitate the use of costly hospital resources, extend inpatient stays, and carry an increased 
potential for morbidity and mortality.2 Antimicrobials may be bactericidal or bacteriostatic. 
Bactericidals work by killing the microorganisms that they come into contact with while 
bacteriostatics inhibit the growth of microorganisms.  
Two standard antimicrobial compounds used for pre-surgical skin preparation are chlorhexidine 
gluconate (CG) and povidone-iodine (PI). These compounds are bactericidal, therefore, they 
rapidly reduce the number of transient and resident microorganisms in the surgical field as well 
as suppress rebound growth for several hours after application.3 The solutions applied to the skin 
prior to surgical incision, CG and PI, are used about equally across the United States and may be 
in an aqueous or alcoholic solution with varying concentrations. Our study aims to compare the 
efficacy of 2% chlorhexidine gluconate solutions to 10% povidone–iodine solutions regarding 
the prevention of post-operative SSIs in adult patients within 30 days of undergoing a clean-
contaminated surgery.  
Methods 
PubMed was the only database used to find the articles for this study. The search was performed 
using the terms chlorhexidine, infection control, iodophors, and surgical site infection. The limits 
used for the search included “randomized controlled trial, published within 10 years, and 
humans”. This search resulted in 66 results of which 10 were chosen to investigate further. Of 
the 10, three were determined to have met the inclusion and exclusion criteria seen in Table 1. 
Each study was reviewed to identify the presence of relative risk statistics or data needed to 
calculate relative risks. 
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Table 1. Inclusion and Exclusion Criteria of Studies Accepted For Systemic Review 
Inclusion Criteria Exclusion Criteria 
-18+ Years Old 
-Concentration of 2% Chlorhexidine 
Gluconate Solution 
-Concentration of 7.5% or 10% Povidone – 
Iodine Solution 
-Clean-Contaminated Surgery 
-30 Day Observation Period Post-Surgery 
- <18 Years Old 
-Less than 30 days of follow-up 
-Non-comparable concentrations of 
antiseptics 
-Clean, Contaminated, or Dirty Surgery 
 
 
Figure 1. Prisma Flow Chart 
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Results 
Study 1 
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis.2  
Objective: 
“To compare the efficacy of chlorhexidine–alcohol with that of povidone–iodine for preventing 
surgical-site infections”. 2  
Study Design: 
This randomized control trial was conducted at six university affiliated hospitals in the United 
States. 
Table 2. Inclusion and Exclusion Criteria of Study 1 
Inclusion Criteria Exclusion criteria 
-Patients 18 years of age  
-Undergoing clean-contaminated 
surgery 
-History of allergy to chlorhexidine, alcohol, iodophors.  
-Evidence of infection at or adjacent to the operative site.  
-The perceived inability to follow the patient's course for 
30 days after surgery 
 
Patients were randomly assigned in a 1:1 ratio to have the skin at the surgical site prepped with a 
2% chlorhexidine gluconate solution or a 10% povidone-iodine solution. Randomization was 
achieved with the use of computer-generated sorting with no blocking. This system helped to 
address potential interhospital differences with the two groups. The operating surgeon only 
became aware of the intervention when the patient entered the operating room. 
The first group was preoperatively scrubbed with ChloraPrep (2% chlorhexidine gluconate and 
70% isopropyl alcohol). If the area exceeded 33cm x 33cm, more than one applicator was used. 
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The second group was preoperatively scrubbed and then painted with a Scrub Care Skin Prep 
Tray (aqueous solution of 10% povidone–iodine). 
The outcome of the study was measured by the presence of surgical site infections within 30 
days after surgery. Secondary outcomes included the specific type of surgical site infection 
present differentiated into “superficial incisional infection (which involved only skin and 
subcutaneous tissue and excluded stitch-related abscesses), deep incisional infection (which 
involved fascia and muscle), or organ-space infection (which involved any organ or space other 
than the incised layer of body wall that was opened or manipulated during the operation)” 2 
Study results: 
A total of 849 qualified participants were included in the study; 409 used the chlorhexidine-
alcohol solution, and 440 used povidone-iodine solution. Of the total 897 participants, 36 were 
excluded from the per-protocol analysis: “25 underwent clean rather than clean-contaminated 
surgery, 4 dropped out of the study 1 or 2 days after surgery, and 7 died before completion of the 
30-day follow-up (4 in the chlorhexidine–alcohol group and 3 in the povidone–iodine group)”.  
Each patient was given systemic prophylactic antibiotics one hour before the first incision. “For 
the patients in the intention-to-treat population, the overall rate of surgical-site infection was 
significantly lower in the chlorhexidine–alcohol group (9.5%) than in the povidone–iodine group 
(16.1%, P=0.004)”.  
Additionally, chlorhexidine-alcohol was associated with fewer secondary superficial incisional 
infections (relative risk, 0.48; 95% CI, 0.28 to 0.84) and deep incisional infections (relative risk, 
0.33; 95% CI, 0.11 to 1.01). There was no difference between organ-space infection and sepsis 
from SSI. 2 
 8 
Study Critique: 
A large number of participants and high rate of compliance were major strengths of this study. 
The study also accounted for variability in many aspects such as systemic prophylactic 
antibiotics in which there was no significant difference in type or number of antibiotics used; 
assessing the effects between group and surgery type, which was found to be not significant; and 
a Breslow-Day test indicated no significant difference between the incidence of either any type 
of surgical-site infection (P=0.35) or individual types of infection (P≥0.19). 2 
 
 Study 2 
Is chlorhexidine-gluconate superior than Povidone-Iodine in preventing surgical site infections? 
A multicenter study. 4 
 Objective: 
“To compare the efficacy of povidone-iodine and chlorhexidine gluconate scrubs in preventing 
surgical site infections”.4 
Study Design: 
A randomized control trial was conducted in two major public sector hospitals in Karachi and 
Islamabad, Pakistan. 4 
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Table 3. Inclusion and Exclusion Criteria of Study 2 
Inclusion Criteria Exclusion Criteria 
-Patients 18-60 years old 
-Undergoing clean or contaminated 
surgery 
-Diabetes 
-Infection adjacent to surgical site 
-Undergoing emergency surgery and unwilling to 
participate 
  
A total of 400 participants were included in this study: 200 from a general surgery unit at Jinnah 
Postgraduate Medical Centre and 200 from a surgical unit at Pakistan institute of Medical 
Sciences. A predesigned proforma was used to record the patient’s surgical procedure, 
prophylactic antibiotics, and pre-surgical antiseptic agent. A day before surgery patients were 
randomly assigned to one of the treatment groups. Randomization was done by lottery ticket 
method where the investigator picked slips for each patient. Group I was comprised of patients 
scrubbed with 10% povidone- iodine, and group II was scrubbed with 2% chlorhexidine-
gluconate in 70% isopropyl alcohol. The operating surgeon and staff knew which surgical 
preparation was being used. 
All patients were monitored daily for any sign of surgical site infection post-surgery. They used 
the Center of Disease Control’s definition which states, “Infection would be regarded as surgical 
site infection if it occurs within 30 days of procedure and has at least one of the following 
symptoms; purulent drainage from the wound, pain or tenderness, localized swelling, redness, 
malodor, or fever”. Patients visited the outpatient department weekly after discharge to assess for 
SSIs. 4 
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Study Results: 
Of the 400 participants, 352 completed the study. Group I had 207 participants, and group II had 
151 participants. “Overall, 22 (10%) patients developed SSI in group I, while 12 (7.1%) patients 
from group II developed SSI during follow-up. Although infection rates were lower in group II 
compared to group I, intention-to-treat analysis showed that this difference was not statistically 
significant (p=0.324)”.1 Additionally, the use of prophylactic antibiotics in both groups showed 
no statistically significant difference. 4 
Study Critique: 
There was a large discrepancy in the size of each study group. To make up for this, additional 
analysis was completed (p-values, chi-squared test). A strength of this study was the exclusion 
criteria which controlled confounding variables such as high-risk groups and prophylactic 
antibiotics. 
 
 Study 3 
Randomized clinical trial of preoperative skin antisepsis with chlorhexidine gluconate or 
povidone–iodine.3  
Objective: 
Compare the efficacy of chlorhexidine gluconate and povidone-iodine on surgical site infections 
in clean-contaminated abdominal surgery. 3 
Study design: 
This randomized study took place in Korea, but the specific region or facility is not noted.  
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Table 4. Inclusion and Exclusion Criteria of Study 3 
Inclusion Criteria Exclusion Criteria 
-Undergoing hepatobiliary–pancreatic 
(HBP) surgery 
  
  
-Allergy to chlorhexidine or povidone 
-Taking an immunosuppressant 
-Uncontrolled diabetes mellitus 
-BMI > 30kg/m^2 
  
Patients undergoing clean-contaminated upper gastrointestinal or hepatobiliary–pancreatic open 
surgery between 2011 and 2014 were assigned to be preoperatively scrubbed with chlorhexidine 
gluconate or povidone–iodine. Before surgery, patients in the CG group were soaped with 4% 
CG and then painted with 2% solution of CG. Patients in the PI group were soaped with 7.5% PI 
and then painted with a 10% aqueous solution. After three minutes of drying, the surgical nurse 
dried the skin with a sterile fabric towel. 
All patients were given preoperative antibiotics within one hour of skin incision. Monitoring for 
SSIs began 48 hours post-operatively. “The primary endpoint was the occurrence of SSI within 
30 days of surgery. Secondary endpoints included causative organisms and risk factors for SSI.” 
This study defined SSI as, “infection arising from a surgical procedure and occurring within 30 
days of surgery” 3 
Study Results: 
Of the 597 participants, 534 were included in the study, and the study groups were equal in size. 
The overall SSI rate was 5.8%; superficial SSI developed in 9 patients, deep SSI in 12 patients, 
and organ-space SSI in ten patients. There was no different in overall rate of SSIs between the 
CG group and PI group. Of the CG group, 15 of 267 (5.6%) experienced SSI and of the PI group, 
16 of 267 (6.0%; P =0.853) experienced SSI. 3 
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Study critique: 
The aqueous solution was patted dry which may have decreased the sustained bactericidal effect. 
This study had a limited scope of surgeries as the SSI rate was only evaluated for upper 
gastrointestinal or hepatobiliary operations.  
 
Discussion 
Darouiche et al found that the application of 2% CG reduced the incidence of SSIs by 41% 
compared to 10% PI. This study demonstrated statistical significance as seen in table 5. (p = 
0.0049). The superior clinical efficacy is likely due to its more rapid onset of action, persistent 
activity, and residual effect. Bibi et al found a 45.4% reduction in SSI rates with the use of 2% 
CG compared to 10% PI but was not statistically significant (table 5). Park et al found no 
difference between 2% CG and 10% PI on reduction of SSIs. This could be due to the rate of 
SSIs in this study being low overall. Additionally, the 2% CG was patted dry to shorten the dry 
time but may have decreased the sustained bactericidal effect.    
Some limitations were noted between the three studies chosen. The first included differences in 
application of 2% CG and 10% PI. A step-by-step approach was not provided to ensure all 
application processes were identical which could have resulted in confounding variables. Some 
patients were “scrubbed” and others “painted” or “soaped” with the exact mechanism 
undisclosed. Additionally, Darouiche et al and Bibi et al used 10% PI solutions whereas Park et 
al used an aqueous 10% PI solution. Effectiveness against SSIs regarding different types of 
solutions is unknown. Each study was completed in a different country (Pakistan, United States, 
and Korea). The protocols and standards upheld at each institution are not known. Park et al did 
not disclose information of the facility where surgery took place or where patients were treated 
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and monitored post-operatively. Dariouche et al allowed hospitals to continue their pre-existing 
practices such as pre-operative showering which could alter the efficacy of 2% CG and 10% PI. 
Finally, the prevalence of the most common SSI microbiological flora may differ from each 
facility/country where each study was conducted. 
Limited biases were found due to adequate blinding. One potential source of bias was included in 
Park et al where the surgeon was made aware of the pre-operative intervention applied. All other 
surgeons were blinded until the patient entered the operating room.   
Strengths of the studies included large sample sizes (849, 352, 534) with near equivalent study 
participants in each CG and PI group. Each study applied respectable exclusion criteria to rule 
out comorbidities that could have significant effects on the results. Each study used the same 
concentration of 2% CG and 10% PI and only included clean-contaminated surgeries.  
 Table 5. Comparison of Statistical Analysis of Studies.  
 Antiseptic Solution Relative 
Risk 
95% 
Confidence 
Interval 
P-Value 
Study 1 Chlorhexidine-
Gluconate 
0.59 0.41-0.85 0.0049 
Povidone-Iodine 1.7 1.17-2.44 0.0049 
Study 2 Chlorhexidine-
Gluconate 
0.75 0.38-1.5 0.3961 
Povidone-Iodine 1.3 0.68-2.6 0.3961 
Study 3 Chlorhexidine-
Gluconate 
0.93 0.47-1.9 0.8532 
Povidone-Iodine 1.1 0.54-2.1 0.8532 
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Conclusion 
Given the limited research currently available, there is not a significant difference between the 
rate of SSIs when using CG or PI in the setting of clean-contaminated surgeries. More research 
needs to be conducted to further evaluate if one of these skin antiseptics is significantly more 
efficacious than the other. Future studies should be done on these antiseptics in the settings of 
clean and contaminated wounds in addition to the previously studied clean-contaminated for a 
broader scope of research.  
Because no significant difference between the SSI rate and CG or PI has been identified at this 
time, the antiseptics may be used interchangeably depending on allergy, cost, and convenience. 
Allergies to PI and CG have both been identified in patients. However, there is no cross- 
reactivity between these two antiseptics so a patient with an allergy to one may readily try the 
other. 5 
Regarding cost, the antiseptic with a better value per volume should be chosen. This will allow 
for a competitive market leading to control over antiseptic costs and will allow hospitals to keep 
costs down. The convenience of available antiseptics should also be taken into account when 
selecting an agent for skin antisepsis. This is especially important in the setting of non-elective 
surgeries when time cannot be wasted. 
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